The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRenold Regulatory News (RNO)

Share Price Information for Renold (RNO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 51.20
Bid: 50.40
Ask: 51.20
Change: 0.80 (1.59%)
Spread: 0.80 (1.587%)
Open: 51.00
High: 51.20
Low: 50.00
Prev. Close: 50.40
RNO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Re Pensions

7 Dec 2015 07:00

RNS Number : 1269I
Renold PLC
07 December 2015
 

Renold plc

("Renold" or "the Company" or "the Group")

 

Re: Lowering risk and reducing liabilities for pension schemes

 

Renold, a leading international supplier of industrial chains and related power transmission products, announces further actions to reduce and de-risk pension liabilities in the UK and Germany.

 

UK: Second medically underwritten insured buy-in

The Renold Pension Scheme (the Group's UK legacy Defined Benefit pension scheme, 'the RPS') has completed a second medically underwritten insured buy-in that fully de-risks another £27m (approximately 25%) of the current UK pensioner liabilities (1) and follows a similar transaction in April 2015. Both transactions were in respect of the highest risk pensioner members (2) and the transaction announced today results in approximately 50% of current UK pensioner liabilities being fully de-risked.

 

Similarly attractive pricing terms were obtained compared to the April transaction and hence the RPS was again able to secure the liabilities at a small discount to their assumed funding valuation. As a result, the transaction has improved the funding level of the RPS in addition to the further reduction in risk. The transaction is broadly neutral from an accounting valuation perspective and was structured as a 'buy-in' and hence the insurance policy remains an asset of the scheme. Consideration for the buy-in will be sourced entirely from a portion of the scheme's holding of high quality corporate bonds. The Group has agreed that a modest acceleration of up to £1.0m of contingent cash contributions that would have been payable in the financial year ending March 2018, will be made in the financial year ending March 2017.

 

The Group is now fully protected against risks arising from volatility in longevity, inflation and interest rates in respect of these members. These factors will be relevant to future triennial revaluations and funding discussions with Trustees.

 

Closure of unfunded German pension scheme to future accrual

A German court has confirmed that the pension scheme of the Group's subsidiary in Germany was properly closed to future accrual with effect from 30 September 2013. This is expected to result in a reduction in the Group's unfunded pension obligations of approximately 6.0% or £1.5m, based on market conditions and exchange rates as at 30 September 2015 and will be fully disclosed in the Group's Annual Report and Accounts for the year ending 31 March 2016. The confirmed closure also reduces annual service costs as well as eliminating the German scheme's exposure to the risk of salary inflation.

 

Robert Purcell, Chief Executive of Renold, commented:

 

"These actions significantly reduce and further de-risk our pension liabilities in the UK and Germany. At the same time, they lower future funding costs and thus protect the Group's ability to invest further in the business. They are also important milestones in rebuilding the Group's balance sheet and delivering sustainable gains in shareholder value."

 

7 December 2015

 

(1) Liabilities assessed on a scheme funding basis

(2) High liability members from a scheme perspective are those with higher annual pension incomes who represent a significant concentration of longevity risk for the scheme.

 

 

ENQUIRIES:

 

Renold plc

0161 498 4500

Robert Purcell, Chief Executive

Brian Tenner, Finance Director

Instinctif

020 7457 2020

Mark Garraway

Helen Tarbet

 

 

 

 

 

 

 

 

NOTES FOR EDITORS

 

Renold is a global leader in the manufacture of industrial chains and also manufactures a range of torque transmission products which are sold throughout the world to a broad range of original equipment manufacturers and distributors. The Company has a well deserved reputation for quality that is recognised worldwide. Its products are used in a wide variety of industries including manufacturing, transportation, energy, steel and mining.

 

Further information about Renold can be found on the website at: www.renold.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCUNUWRVKAURAA
Date   Source Headline
18th Jun 20198:00 amRNSAnnual Report and Accounts
17th Jun 201912:07 pmRNSSecond Price Monitoring Extn
17th Jun 201912:02 pmRNSPrice Monitoring Extension
7th Jun 20198:05 amRNSAdmission to trading on AIM
4th Jun 20195:30 pmRNSRenold
3rd Jun 201911:30 amRNSSchedule One update - Renold plc
3rd Jun 20197:00 amRNSTimetable update
28th May 20197:00 amRNSFinal Results
8th May 20191:54 pmRNSResult of General Meeting
8th May 201911:30 amRNSSchedule 1 - Renold Plc
11th Apr 20192:42 pmRNSPosting of shareholder circular
11th Apr 20197:01 amRNSTrading Update
11th Apr 20197:00 amRNSProposed move from Official List to AIM
1st Apr 20197:00 amRNSExtension of Banking Facilities
4th Feb 20198:00 amRNSBlock listing Interim Review
28th Jan 201912:53 pmRNSHolding(s) in Company
16th Nov 20182:39 pmRNSHolding(s) in Company
16th Nov 20182:38 pmRNSHolding(s) in Company
16th Nov 20182:35 pmRNSHolding(s) in Company
15th Nov 201812:02 pmRNSPrice Monitoring Extension
14th Nov 20187:01 amRNSAppointment of Non-Executive Director
14th Nov 20187:00 amRNSHalf-year Report
11th Oct 20187:00 amRNSTrading Update
2nd Oct 20187:00 amRNSAppointment of Broker
2nd Aug 20189:00 amRNSBlock listing Interim Review
18th Jul 20181:26 pmRNSResult of AGM
18th Jul 20187:00 amRNSAGM Statement
14th Jun 20182:09 pmRNSDirector/PDMR Shareholding
14th Jun 20187:00 amRNSAnnual Report and Accounts
8th Jun 201812:49 pmRNSGrant of Awards - Performance Share Plan
31st May 20182:54 pmRNSDirector/PDMR Shareholding
31st May 20182:46 pmRNSDirector/PDMR Shareholding
31st May 201810:05 amRNSDirector/PDMR Shareholding
31st May 20188:47 amRNSDirector/PDMR Shareholding
30th May 20188:38 amRNSDirector/PDMR Shareholding
29th May 20187:00 amRNSFinal Results
25th Apr 201810:07 amRNSHolding(s) in Company
24th Apr 201810:06 amRNSHolding(s) in Company
20th Apr 20187:00 amRNSNotice of Results
19th Apr 20183:16 pmRNSHolding(s) in Company
19th Apr 20188:41 amRNSHolding(s) in Company
18th Apr 20189:02 amRNSHolding(s) in Company
10th Apr 20189:55 amRNSHolding(s) in Company
9th Apr 201810:21 amRNSHolding(s) in Company
3rd Apr 201810:46 amRNSHolding(s) in Company
9th Mar 20187:00 amRNSTrading Update
6th Feb 20184:35 pmRNSPrice Monitoring Extension
2nd Feb 20188:00 amRNSBlock listing Interim Review
14th Nov 20177:00 amRNSHalf-year Report
26th Oct 20173:07 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.